Table 3

Deaths prevented or postponed by medical and surgical treatments in the West Bank in 2009

			Coronary heart disease deaths prevented or postponed			Proportion of overall deaths prevented or postponed (%)
Treatments	Patients eligible	Treatment uptake (%)	Best estimate	Minimum estimate	Maximum estimate	Proportion of overall deaths prevented or postponed (%)
Acute myocardial infarction	489		2	1	6	−1.9
Hospital resuscitation		0.06	0	0	1	−0.3
Thrombolysis and aspirin
Aspirin alone		0.90	5	2	9	−3.8
Thrombolysis alone		0.39	3	1	6	−2.4
β-Blockers		0.58	1	0	2	−0.6
ACE inhibitors		0.44	1	0	2	−1
Secondary preventionpostinfarction	2266		9	4	30	−7.4
Aspirin		0.483	4	1	9	−2.9
β-Blockers		0.388	4	1	11	−3.6
Aspirin and β-blockers		0.415	4	1	10	−3.4
ACE inhibitors		0.472	5	2	13	−4.2
Statins		0.046	0	0	1	−0.4
Warfarin		0.100	1	0	3	−0.9
Rehabilitation		0.483	1	0	3	−0.9
Secondary preventionpostrevascularisation	208		2	0	6	− 1.9
Angina			7	6	13	−5.7
Coronary Artery Bypass Grafting surgery (2004–2005)	208	1	6	3	10	−4.6
Aspirin in the community	22180	0.47	15	13	40	−12.7
Statin in the community	22180	0.46	20	11	50	−16.8
Unstable angina	489		1	2	9	−1.1
Heart failure	2811
Hospital patients	468		−2	−1	−8	−1.5
Community patients	2342		−7	−4	−4	−5.4
Hypertension treatments			−5	−2	−23	−4.1
Total treatment effects			35	20	108	29